Ayala Pharmaceuticals EBITDA margin
What is the EBITDA margin of Ayala Pharmaceuticals?
The EBITDA margin of Ayala Pharmaceuticals Inc. is -3,053.60%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with ebitda margin similar to Ayala Pharmaceuticals
- CytoTools AG has EBITDA margin of -3,161.77%
- Workhorse Inc has EBITDA margin of -3,157.57%
- Battery Minerals has EBITDA margin of -3,123.92%
- Great Southern Mining has EBITDA margin of -3,122.95%
- ReNu has EBITDA margin of -3,072.39%
- Central Iron Ore has EBITDA margin of -3,056.47%
- Ayala Pharmaceuticals has EBITDA margin of -3,053.60%
- QuantGate Systems has EBITDA margin of -3,050.56%
- Quantgate Sys Inc has EBITDA margin of -3,050.56%
- Field Trip Health has EBITDA margin of -3,048.55%
- Sheffield Resources has EBITDA margin of -3,043.37%
- King Island Scheelite has EBITDA margin of -3,021.85%
- Kintor Pharma B has EBITDA margin of -2,997.62%